How Do Regulatory Bodies Ensure the Safety of Biomaterials?
Regulatory agencies, such as the FDA and the European Medicines Agency (EMA), provide guidelines for the evaluation and approval of biomaterials. These guidelines include rigorous testing protocols to assess the toxicity, biocompatibility, and overall safety of new materials before they can be used in clinical settings. Compliance with these regulations is essential to ensure that biomaterials do not pose undue risks to patients.
